LaFleur & Godfrey LLC maintained its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, Holdings Channel reports. The fund owned 53,218 shares of the medical instruments supplier’s stock at the end of the second quarter. LaFleur & Godfrey LLC’s holdings in DENTSPLY SIRONA were worth $3,451,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC increased its position in shares of DENTSPLY SIRONA by 4.3% in the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 673,830 shares of the medical instruments supplier’s stock valued at $42,074,000 after buying an additional 27,860 shares during the last quarter. BlackRock Inc. increased its position in shares of DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock valued at $867,376,000 after buying an additional 13,457,730 shares during the last quarter. Schwab Charles Investment Management Inc. increased its position in shares of DENTSPLY SIRONA by 3.1% in the first quarter. Schwab Charles Investment Management Inc. now owns 710,579 shares of the medical instruments supplier’s stock valued at $44,369,000 after buying an additional 21,456 shares during the last quarter. Shelton Capital Management increased its position in shares of DENTSPLY SIRONA by 84.2% in the first quarter. Shelton Capital Management now owns 27,056 shares of the medical instruments supplier’s stock valued at $1,689,000 after buying an additional 12,368 shares during the last quarter. Finally, Farmers & Merchants Investments Inc. increased its position in shares of DENTSPLY SIRONA by 3.6% in the first quarter. Farmers & Merchants Investments Inc. now owns 94,521 shares of the medical instruments supplier’s stock valued at $5,902,000 after buying an additional 3,300 shares during the last quarter. 95.17% of the stock is owned by hedge funds and other institutional investors.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at 55.33 on Friday. DENTSPLY SIRONA Inc. has a one year low of $54.49 and a one year high of $65.68. The company’s market capitalization is $12.70 billion. The company has a 50-day moving average price of $62.91 and a 200 day moving average price of $62.30.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.65. The business had revenue of $992.70 million for the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The business’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.76 EPS. Equities analysts anticipate that DENTSPLY SIRONA Inc. will post $2.73 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be paid a $0.0875 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.63%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -10.09%.

WARNING: “DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stake Held by LaFleur & Godfrey LLC” was published by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/12/dentsply-sirona-inc-nasdaqxray-stake-held-by-lafleur-godfrey-llc.html.

Several analysts have recently weighed in on the company. TheStreet cut DENTSPLY SIRONA from a “b” rating to a “c+” rating in a report on Wednesday. UBS AG restated a “neutral” rating and set a $59.00 price target (down from $62.00) on shares of DENTSPLY SIRONA in a report on Thursday. Morgan Stanley boosted their price target on DENTSPLY SIRONA from $66.00 to $67.00 and gave the stock an “overweight” rating in a report on Thursday. Stifel Nicolaus restated a “buy” rating and set a $66.00 price target (down from $70.00) on shares of DENTSPLY SIRONA in a report on Thursday. Finally, BidaskClub cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have assigned a buy rating to the company’s stock. DENTSPLY SIRONA presently has an average rating of “Buy” and an average price target of $66.75.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.